Normal colon lining
The inner lining of the colon is renewed regularly. Normal cells grow, divide and die in a controlled way.
Colon cancer is a disease in which abnormal cells grow out of control in the tissues of the colon, also called the large intestine. It is often discussed together with rectal cancer under the term colorectal cancer because both affect parts of the large bowel.
Colon cancer is a malignant disease that starts in the colon. The colon is part of the digestive system and helps absorb water and form stool before waste moves toward the rectum.
Colon cancer forms when cells in the lining or tissues of the colon acquire biological changes that allow uncontrolled growth, invasion into nearby tissue and, in some cases, spread to lymph nodes or distant organs.
Many colorectal cancers begin as polyps, which are growths on the inner lining of the colon or rectum. Not all polyps become cancer, but some types can develop into cancer over time.
The inner lining of the colon is renewed regularly. Normal cells grow, divide and die in a controlled way.
A polyp is a tissue growth that may form on the colon lining. Some polyps are harmless, while others may carry cancer risk.
Genetic and epigenetic changes can affect growth control, DNA repair and cell-death pathways.
Cancer cells may invade deeper layers of the colon wall and interact with blood vessels, immune cells and surrounding tissue.
Most colon cancers are adenocarcinomas, meaning they begin in gland-forming cells of the colon lining. Other tumor types are less common but may occur.
The most common colon cancer type. It arises from glandular cells that produce mucus and line the inner surface of the colon.
Some colon cancers are associated with inherited syndromes such as Lynch syndrome or familial adenomatous polyposis.
Long-standing inflammatory bowel disease, including ulcerative colitis or Crohn’s disease affecting the colon, can increase colorectal cancer risk.
Colon cancer biology involves tumor initiation, uncontrolled cell growth, immune interactions, inflammation, blood vessel formation, invasion and possible metastasis.
APC pathway changes are often discussed in colorectal tumor development and polyp progression.
KRAS-related signaling can influence proliferation, survival and downstream pathway activation.
TP53 biology is important in genomic instability, cell-cycle regulation and apoptosis research.
Mismatch repair deficiency and microsatellite instability are important molecular features in colorectal cancer research.
Colon cancer may not cause symptoms early. When symptoms occur, they can overlap with many non-cancer conditions, so persistent or concerning symptoms should be discussed with a healthcare professional.
Colon cancer risk can be influenced by age, personal history, family history, inherited syndromes, inflammatory bowel disease and lifestyle-related factors.
Risk generally increases with age, although younger-adult cases are increasingly recognized in several countries.
A personal or family history of colorectal polyps or colorectal cancer can increase risk.
Crohn’s disease or ulcerative colitis involving the colon can increase long-term risk.
Lynch syndrome and familial adenomatous polyposis are important hereditary risk syndromes.
Diet, physical activity, body weight, alcohol use and smoking are commonly discussed in prevention research.
Screening can detect abnormal growths before they become cancer or find cancer earlier.
Screening is important because some colorectal cancers begin as polyps. Detecting and removing certain polyps can reduce the chance that they develop into cancer.
Some screening methods can detect abnormal growths in the colon or rectum.
Symptoms are not always present in early disease, so screening can be important even when someone feels well.
People with higher risk may need earlier or different screening plans discussed with a healthcare professional.
Colon cancer starts in the large intestine when cells grow abnormally and form cancer. It may begin from certain polyps, and it can sometimes be found before symptoms appear through screening.
Colon cancer starts in the colon. Colorectal cancer includes both colon cancer and rectal cancer, so colon cancer is one type of colorectal cancer.
No. Colon cancer may cause no symptoms in early stages. When symptoms occur, they may include bowel habit changes, blood in stool, abdominal pain, fatigue or unexplained weight loss.
Some colorectal cancers begin as polyps. Finding and removing certain polyps can help prevent colorectal cancer.
Clear answers to common questions about colon cancer, colorectal cancer, symptoms, risk factors and screening concepts.
Colon cancer is cancer that starts in the tissues of the colon, which is part of the large intestine. It occurs when abnormal cells grow out of control and may form a tumor.
Colon cancer starts in the colon. Rectal cancer starts in the rectum. Colorectal cancer is a broader term that includes both colon and rectal cancer.
Yes. Many colorectal cancers begin as polyps, which are growths on the inner lining of the colon or rectum. Some types of polyps can become cancer over time.
Possible symptoms include a change in bowel habits, blood in or on stool, abdominal pain or cramps, unexplained weight loss, fatigue or a feeling that the bowel does not empty completely.
Risk may be higher with increasing age, personal or family history of colorectal polyps or cancer, inflammatory bowel disease, certain inherited syndromes and some lifestyle-related factors.
No. This page is educational only and does not replace consultation with a qualified healthcare professional.
Authoritative sources used to support the colon cancer education content.